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Psychotic features can be present in both narcolepsy and psychosis, which can result in challenges in diagnosis and management.
The prevalence of both conditions is low and the reports in young people are scarce. Our report illustrates the relevance of a
thorough diﬀerential diagnosis as well as the need to explore treatment avenues based on the evidence available for both narcolepsy
and psychosis symptoms to try and maximise the therapeutic impact.
1. Introduction
Narcolepsy is a chronic neuropsychiatric disorder character-
ized by severe, irresistible daytime sleepiness and symptoms
described as rapid eye movement (REM) sleep-related
symptoms, including sudden loss of muscle tone (cataplexy),
hypnagogic hallucinations, and sleep paralysis. Narcolepsy
was considered a disorder of adulthood, but accumulating
evidence indicates that narcolepsy may start during child-
hood. However, the precise prevalence of hypersomnia in
children is unknown [1]. Narcolepsy and psychosis can share
common features and age of onset, leading to challenges for
diagnosis and subsequent management, as illustrated in case
reports [2–8] and case control studies [9, 10]. These look at
adults [2–10], with anecdotal references to younger patients
[11]. We report on a 17-year-old man with narcolepsy
complicated by psychotic symptoms and the therapeutic
approach followed.
2. Case Report
A 17-year-old man of Chinese ethnicity was admitted to
our unit in 2009 after presenting with auditory and somatic
hallucinations and paranoid delusions, which resulted in an
incident of aggression at home. He had a comorbid diagnosis
of narcolepsy.
2.1. History of Narcolepsy. In 2007 the patient had been
diagnosed with narcolepsy and cataplexy after a history
of recurrent episodes of loss of muscle tone related with
high emotions (i.e., strong laughter) and daytime somno-
lence. The diagnosis had initially been made on clinical
grounds following the ICSD (International Classification
of Sleep Disorders) criteria B and C (B = Recurrent
daytime naps for >3 months and C = Sudden bilateral
loss of muscle tone in association with intense emotion
(cataplexy)) [12]. Polysomnography (PSG) had not been
considered necessary at that stage nor Human Leukocyte
Antigen (HLA) typing as studies on Hong Kong Chinese
narcoleptics [13] had found out that all patients were HLA
DR2- and DQ1-positive so the view then was that it would
not provide any additional relevant information for the
diagnosis. He was receiving followup from a sleep disorder
service and was not on any medication for narcolepsy or
cataplexy.
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While in our unit, arranging further tests (i.e., PSG, Mul-
tiple Sleep Latency Testing-MSLT) was considered but put on
hold due to the young man’s mental health deterioration.
2.2. History of Psychotic Episodes. The patient had several
prior admissions to psychiatric wards in 2008 and 2009.
During his admission in 2008 his psychotic symptoms
appeared to be present mostly at bedtimes in the form
of hypnagogic and hypnopompic hallucinations with little
evidence of psychosis during the day. The opinion then was
that the underlying narcolepsy could explain his psychotic
experiences so his antipsychotic medication (amisulpride)
was subsequently reduced without any evidence of deterio-
ration in his mental state.
In his admission in 2009 his presentation appeared dif-
ferent, with paranoid symptoms and auditory hallucinations,
which responded to haloperidol. However, due to complaints
of sleepiness the medication was changed to aripiprazole.
His compliance was erratic, with clear deterioration of his
symptoms when noncompliant. At discharge he was given a
diagnosis of hebephrenic schizophrenia.
2.3. Physical History and Other Additional Investigations. In
2008 a WISC-IV (Wechsler Intelligence Scale for Children,
version IV) was completed to clarify the nature of his
diﬃculties retaining information. The result suggested that
this was not related to his cognitive abilities, which were in
the low-average range.
In 2009 he had an MRI (Magnetic Resonance Imaging)
of the brain and EEG (Electroencephalogram) that were both
reported as normal.
In his admission to our unit in 2010, input from Speech
and Language Therapy was sought to assess the fact that his
mother tongue was Chinese, which caused the subsequent
cross-cultural barrier and the possible impact of this on
his presentation and interpretation of his symptoms. This
assessment did not suggest that his language or cultural
factors were contributing factors to the described clinical pic-
ture. In addition, his physical examination, blood tests, and
toxicological screening did not exhibit significant alterations.
2.4. Progress in Our Unit. His medication was increased from
4mg/d to 6mg/d risperidone with incomplete symptom
resolution. He continued to experience auditory hallucina-
tions and showed incongruent aﬀect. He was impaired in
his functioning, particularly in his thought processing. As
in his admission in 2008, some of his psychotic symptoms
(i.e., tactile and somatic hallucinations) seemed to be only
present around sleeping times. His sleep was disturbed at the
night (i.e., shouting, singing, or responding to voices whilst
asleep) and following the awakening either from night sleep
or frequent naps in relation to his daytime sleepiness, he
had substantial diﬃculties to process and respond to verbal
information. It is possible that these behaviours were the
result of REM sleep behaviour disorder (RBD). There is
evidence in the literature that RBD is present in up to a third
of patients with narcolepsy [14].
To try to clarify the clinical picture, in consultation with
his consultant at the Sleep Disorder Clinic, we started him
on a trial of 7.5mg/d zopiclone, which proved eﬀective to
stop the described night-time somatic hallucinations. As
daytime sleepiness and marked diﬃculties in concentration
and thought process were still quite noticeable, a dose
of 200mg/d modafinil was tried with significant positive
impact on concentration and daytime general function.
Significant thought disorder and distraction remained so a
trial of Clozapine was started. Unfortunately, it had to be
discontinued due to adverse haematological results.
3. Discussion
Narcolepsy can be related to psychosis in three ways [3,
4]: coexisting with a psychotic disorder; as a side eﬀect
of central stimulants used in the treatment for narcolepsy
[15]; or in relation to sensory misperceptions and other
narcolepsy symptoms that may form delusions and simulate
a psychotic disorder. Several case reports and clinical studies
report that hypnagogic and hypnopompic hallucinations
can be misinterpreted as the active psychotic state of
schizophrenia and lead to misdiagnoses and inappropriate
treatment [2–17]. Szu¨cs et al. [6] postulate that there is a
subgroup of narcolepsy characterized by frequent hypna-
gogic/hypnopompic hallucinations and sleepiness in which
daytime hallucinations are of convincing nature for the
patient, who may be disturbed in his/her reality testing. It
is therefore understandable how the diﬀerentiation between
psychosis and narcolepsy may become problematic. Some
good points to help clinicians in the diﬀerential diagnosis are
personality deterioration and thinking disturbance, which
seemed a relevant feature in the case we are discussing. Our
patient had clear thought-processing diﬃculties, with frank
formal thought disorder at times, loss of social functioning
(i.e., deterioration of academic performance and engage-
ment with peers, with no concerns on these areas prior to
his first admission), inappropriate aﬀect and lack of insight
into his illness, which all seem to support a diagnosis of
schizophrenia with comorbid narcolepsy. However, the fact
that some of his symptoms were clearly related to his sleep
pattern appeared to indicate that narcolepsy was playing a
more causal role in those symptoms. The response to the
trial with zopiclone and modafinil proved that approach
helpful, as the nonsleep related psychotic symptoms became
more evident, making clear that a psychopharmacological
approach with antipsychotic medication was appropriate to
address them.
The fact that the diagnosis of narcolepsy that was based
on clinical grounds and further testing (i.e., PSG, MSLT)
had to be put on hold resulted in some diﬃculties teasing
out which symptoms were due to which conditions. It is not
possible to state whether having additional data would have
changed our management plan.
In their practice, clinicians can encounter challenging
cases with unusual presentations where there may be limited
evidence-based knowledge with which to make treatment
decisions. In these situations, as our case illustrates, careful
consideration and assessment of the clinical picture, history
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of the symptoms, discussion and consultation with relevant
professionals, and subsequent supervised trials of treatment
proved a helpful pragmatic approach in making decisions on
how to manage a complex presentation.
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